Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:03:52 EDT Sun 11 Oct 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for U:ANIX from 2025-10-10 to 2026-10-09 - 39 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-05 08:15U:ANIXNews ReleaseAnixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
2026-10-01 08:35U:ANIXNews ReleaseAnixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
2026-09-21 08:45U:ANIXNews ReleaseAnixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
2026-09-16 09:15U:ANIXNews ReleaseAnixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
2026-09-09 08:35U:ANIXNews ReleaseAnixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-09-03 08:00U:ANIXNews ReleaseAnixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
2026-08-24 08:55U:ANIXNews ReleaseAnixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
2026-08-18 08:45U:ANIXNews ReleaseAnixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-07-06 08:30U:ANIXNews ReleaseAnixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
2026-06-29 08:45U:ANIXNews ReleaseAnixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
2026-06-26 09:10U:ANIXNews ReleaseAnixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
2026-06-11 09:05U:ANIXNews ReleaseAnixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
2026-06-01 09:00U:ANIXNews ReleaseAnixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
2026-05-11 11:48U:ANIXNews Release/C O R R E C T I O N -- Anixa Biosciences, Inc./
2026-05-11 08:55U:ANIXNews ReleaseAnixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
2026-05-01 09:15U:ANIXNews ReleaseAnixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2026-04-29 09:10U:ANIXNews ReleaseAnixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
2026-04-22 08:45U:ANIXNews ReleaseAnixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
2026-04-09 09:05U:ANIXNews ReleaseAnixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
2026-04-07 08:55U:ANIXNews ReleaseAnixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
2026-04-06 09:10U:ANIXNews ReleaseAnixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
2026-04-01 08:50U:ANIXNews ReleaseAnixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
2026-03-30 09:05U:ANIXNews ReleaseAnixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
2026-03-12 10:38U:ANIXNews ReleaseAnixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
2026-03-09 08:30U:ANIXNews ReleaseAnixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
2026-03-02 09:10U:ANIXNews ReleaseAnixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
2026-02-23 08:55U:ANIXNews ReleaseAnixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
2026-02-09 08:00U:ANIXNews ReleaseAnixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
2026-02-02 09:00U:ANIXNews ReleaseAnixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
2026-01-27 08:30U:ANIXNews ReleaseAnixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
2025-12-15 08:45U:ANIXNews ReleaseAnixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
2025-12-11 18:02U:ANIXNews ReleaseAnixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
2025-12-10 09:00U:ANIXNews ReleaseAnixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
2025-11-17 08:15U:ANIXNews ReleaseAnixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
2025-11-12 09:00U:ANIXNews ReleaseAnixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
2025-11-10 10:30U:ANIXNews ReleaseAnixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
2025-11-05 08:55U:ANIXNews ReleaseAnixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
2025-10-23 08:45U:ANIXNews ReleaseAnixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
2025-10-20 08:25U:ANIXNews ReleaseAnixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology